ANO1 overexpression is driven by 11q13 amplification and influences tumor proliferation, invasion, apoptosis resistance, and immune escape. ANO1 also regulates tumor cell-specific pathways, making it a promising biomarker and therapeutic target. This evidence concerns the gene ANO1 and neoplasm.